Publications Repository

Publications Repository

View Item 
  •   Home
  • ICR Divisions
  • Breast Cancer Research
  • View Item
  • Home
  • ICR Divisions
  • Breast Cancer Research
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Abiraterone in patients with recurrent epithelial ovarian cancer: principal results of the phase II Cancer of the Ovary Abiraterone (CORAL) trial (CRUK-A16037)

Thumbnail
View/Open
Published version (821.0Kb)
Publication Date
2020-12-01
ICR Author
Bliss, Judith
Folkerd, Elizabeth
Kaye, Stanley Bernard
Dowsett, Mitch
Kilburn, Lucy
Author
Banerjee, S
Tovey, H
Bowen, R
Folkerd, E
Kilburn, L
McLachlan, J
Hall, M
Tunariu, N
Attygalle, A
Lima, JPDSN
Perry, S
Chatfield, P
Hills, M
Kaye, S
Attard, G
Dowsett, M
Bliss, JM
Type
Journal Article
Metadata
Show full item record
URL
https://repository.icr.ac.uk/handle/internal/4326
Collections
  • Breast Cancer Research
  • Clinical Studies
  • Molecular Pathology
  • Closed Research Teams
Version of record
10.1177/1758835920975352
Subject
Science & Technology
Life Sciences & Biomedicine
Oncology
abiraterone
androgen receptor
CYP17 inhibitor
low grade serous
ovarian cancer
Research team
Clinical Trials & Statistics Unit
Medicine Drug Development Unit (Kaye)
Endocrinology
Language
English
License start date
2020-12-01
Citation
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12 pp. ? - ? (13)
Publisher
SAGE PUBLICATIONS LTD

Browse

All of ICR repositoryICR DivisionsIssue dateAuthorsTitlesSubjectsThis collectionIssue dateAuthorsTitlesSubjects

Statistics

Most popular itemsStatistics by countryMost popular authors
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.